ANGIOTECH PHARMACEUTICALS INC Interest Paid, Including Capitalized Interest, Operating and Investing Activities
ANGIOTECH PHARMACEUTICALS INC reported Interest Paid, Including Capitalized Interest, Operating and Investing Activities of $19.05 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-28.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaid · last filed 2013-03-28
- ANGIOTECH PHARMACEUTICALS INC interest paid, including capitalized interest, operating and investing activities for the quarter ending 2012-12-31 was $6.15M.
- ANGIOTECH PHARMACEUTICALS INC interest paid, including capitalized interest, operating and investing activities for the quarter ending 2012-09-30 was $4.63M, a 11.58% increase year-over-year.
- ANGIOTECH PHARMACEUTICALS INC interest paid, including capitalized interest, operating and investing activities for the quarter ending 2012-06-30 was $4.15M.
- ANGIOTECH PHARMACEUTICALS INC interest paid, including capitalized interest, operating and investing activities for the quarter ending 2012-03-31 was $4.11M.
- ANGIOTECH PHARMACEUTICALS INC interest paid, including capitalized interest, operating and investing activities for fiscal 2012 was $19.05M.
| Period end | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 2 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 3 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 5 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 6 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 8 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 9 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 12 month |
|---|---|---|---|---|---|---|---|
| 2012-12-31 | $6.15M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $10.79M derived: sum of 2 quarters · filed 2013-03-28 | $14.94M derived: sum of 3 quarters · filed 2013-03-28 | $19.05M 10-K · filed 2013-03-28 | |||
| 2012-09-30 | $4.63M 10-Q · filed 2012-11-14 | $8.79M derived: sum of 2 quarters · filed 2012-11-14 | $12.89M 10-Q · filed 2012-11-14 | ||||
| 2012-06-30 | $4.15M 10-Q/A · filed 2012-09-13 | $8.26M 10-Q/A · filed 2012-09-13 | |||||
| 2012-03-31 | $4.11M derived: 10-K 12 month − 3 quarters · filed 2013-03-28 | ||||||
| 2011-12-31 | $11.89M 10-K · filed 2013-03-28 | ||||||
| 2011-09-30 | $4.15M 10-Q · filed 2012-11-14 | $7.78M 10-Q · filed 2012-11-14 | |||||
| 2011-06-30 | $3.63M 10-Q/A · filed 2012-09-13 |